[india-drug] WHO Expert Committee

["Dr. Hans Hogerzeil" <hogerzeilh@who.int>]

WHO Expert Committee on the Selection and Use of Essential
Medicines
------------------------------------------------------------


Dear all,

The next WHO Expert Committee on the Selection and Use of Essential
Medicines will meet from 31 March - 3 April 2003 in Geneva. The Draft 
Agenda and Procedures are posted on the WHO/EDM web site
www.who.int/medicines (in the box "Latest"), the exact location is
http://www.who.int/medicines/organization/par/edl/expertcomm.shtml

Important components of the agenda are:
*	Applications for addition of ibuprofen paediatric formulation,
valaciclovir, miconazole buccal tablet, azithromycin, insulin 
semi-lente, misoprostol, amodiaquine (review of safety) 
*	Application for change of formula of ORS
*	Application to delete nonoxinol
*	Fast-track deletion of certain items
*	Review of all square boxes
*	Review of all core/complementary listings

In the course of the next few weeks the applications, comments and 
other meeting documents will be posted on the web site; some have been
posted already. Documents are accessible by clicking on the relevant
Draft Agenda item, which can be found on
http://www.who.int/medicines/organization/par/edl/expcom13/expcom03agenda.shtml.
Comments on any agenda item are welcome and can be sent to the
Secretary of the Expert Committee or to <grayr@who.int>. 

There will be an open session of the Expert Committee on Monday 31 
March 2003, from 09.30 to 12.30. The agenda of the open session can be
found at
http://www.who.int/medicines/organization/par/edl/expcom13/expcom03open.shtm
l.


Hans V. Hogerzeil, MD, PhD, FRCP Edin
Coordinator for policy, access and rational use
Secretary of the WHO Expert Committee on the Selection and Use of 
Essential Medicines 
Department of Essential Drugs and Medicines Policy
World Health Organisation, 1211 Geneva
Tel +41-22-7913528
Fax +41-22-7914167
<hogerzeilh@who.int>


________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org